Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 113 entries
Sorted by: Best Match Show Resources per page
Dietary practices in propionic acidemia: A European survey.

Molecular genetics and metabolism reports

Daly A, Pinto A, Evans S, Almeida MF, Assoun M, Belanger-Quintana A, Bernabei SM, Bollhalder S, Cassiman D, Champion H, Chan H, Dalmau J, de Boer F, de Laet C, de Meyer A, Desloovere A, Dianin A, Dixon M, Dokoupil K, Dubois S, Eyskens F, Faria A, Fasan I, Favre E, Feillet F, Fekete A, Gallo G, Gingell C, Gribben J, Kaalund Hansen K, Ter Horst NM, Jankowski C, Janssen-Regelink R, Jones I, Jouault C, Kahrs GE, Kok IL, Kowalik A, Laguerre C, Le Verge S, Lilje R, Maddalon C, Mayr D, Meyer U, Micciche A, Och U, Robert M, Rocha JC, Rogozinski H, Rohde C, Ross K, Saruggia I, Schlune A, Singleton K, Sjoqvist E, Skeath R, Stolen LH, Terry A, Timmer C, Tomlinson L, Tooke A, Vande Kerckhove K, van Dam E, van den Hurk T, van der Ploeg L, van Driessche M, van Rijn M, van Wegberg A, Vasconcelos C, Vestergaard H, Vitoria I, Webster D, White FJ, White L, Zweers H, MacDonald A.
PMID: 29021961
Mol Genet Metab Rep. 2017 Oct 03;13:83-89. doi: 10.1016/j.ymgmr.2017.09.002. eCollection 2017 Dec.

BACKGROUND: The definitive dietary management of propionic acidaemia (PA) is unknown although natural protein restriction with adequate energy provision is of key importance.AIM: To describe European dietary practices in the management of patients with PA prior to the publication...

Cite
Daly A, Pinto A, Evans S, et al. Dietary practices in propionic acidemia: A European survey. Mol Genet Metab Rep. 2017;13:83-89doi: 10.1016/j.ymgmr.2017.09.002.
Daly, A., Pinto, A., Evans, S., Almeida, M. F., Assoun, M., Belanger-Quintana, A., Bernabei, S. M., Bollhalder, S., Cassiman, D., Champion, H., Chan, H., Dalmau, J., de Boer, F., de Laet, C., de Meyer, A., Desloovere, A., Dianin, A., Dixon, M., Dokoupil, K., Dubois, S., Eyskens, F., Faria, A., Fasan, I., Favre, E., Feillet, F., Fekete, A., Gallo, G., Gingell, C., Gribben, J., Kaalund Hansen, K., Ter Horst, N. M., Jankowski, C., Janssen-Regelink, R., Jones, I., Jouault, C., Kahrs, G. E., Kok, I. L., Kowalik, A., Laguerre, C., Le Verge, S., Lilje, R., Maddalon, C., Mayr, D., Meyer, U., Micciche, A., Och, U., Robert, M., Rocha, J. C., Rogozinski, H., Rohde, C., Ross, K., Saruggia, I., Schlune, A., Singleton, K., Sjoqvist, E., Skeath, R., Stolen, L. H., Terry, A., Timmer, C., Tomlinson, L., Tooke, A., Vande Kerckhove, K., van Dam, E., van den Hurk, T., van der Ploeg, L., van Driessche, M., van Rijn, M., van Wegberg, A., Vasconcelos, C., Vestergaard, H., Vitoria, I., Webster, D., White, F. J., White, L., Zweers, H., & MacDonald, A. (2017). Dietary practices in propionic acidemia: A European survey. Molecular genetics and metabolism reports, 1383-89. https://doi.org/10.1016/j.ymgmr.2017.09.002
Daly, A, et al. "Dietary practices in propionic acidemia: A European survey." Molecular genetics and metabolism reports vol. 13 (2017): 83-89. doi: https://doi.org/10.1016/j.ymgmr.2017.09.002
Daly A, Pinto A, Evans S, Almeida MF, Assoun M, Belanger-Quintana A, Bernabei SM, Bollhalder S, Cassiman D, Champion H, Chan H, Dalmau J, de Boer F, de Laet C, de Meyer A, Desloovere A, Dianin A, Dixon M, Dokoupil K, Dubois S, Eyskens F, Faria A, Fasan I, Favre E, Feillet F, Fekete A, Gallo G, Gingell C, Gribben J, Kaalund Hansen K, Ter Horst NM, Jankowski C, Janssen-Regelink R, Jones I, Jouault C, Kahrs GE, Kok IL, Kowalik A, Laguerre C, Le Verge S, Lilje R, Maddalon C, Mayr D, Meyer U, Micciche A, Och U, Robert M, Rocha JC, Rogozinski H, Rohde C, Ross K, Saruggia I, Schlune A, Singleton K, Sjoqvist E, Skeath R, Stolen LH, Terry A, Timmer C, Tomlinson L, Tooke A, Vande Kerckhove K, van Dam E, van den Hurk T, van der Ploeg L, van Driessche M, van Rijn M, van Wegberg A, Vasconcelos C, Vestergaard H, Vitoria I, Webster D, White FJ, White L, Zweers H, MacDonald A. Dietary practices in propionic acidemia: A European survey. Mol Genet Metab Rep. 2017 Oct 03;13:83-89. doi: 10.1016/j.ymgmr.2017.09.002. eCollection 2017 Dec. PMID: 29021961; PMCID: PMC5633157.
Copy Download .nbib Format: NLM
Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.

European journal of nuclear medicine and molecular imaging

Temple W, Mendelsohn L, Kim GE, Nekritz E, Gustafson WC, Lin L, Giacomini K, Naranjo A, Van Ryn C, Parisi MT, Shulkin BL, Yanik GA, Kreissman SG, Hogarty M, Matthay KK, DuBois SG.
PMID: 27044383
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1396. doi: 10.1007/s00259-016-3381-x.

No abstract available.

Cite
Temple W, Mendelsohn L, Kim GE, et al. Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group. Eur J Nucl Med Mol Imaging. 2016;43(7):1396doi: 10.1007/s00259-016-3381-x.
Temple, W., Mendelsohn, L., Kim, G. E., Nekritz, E., Gustafson, W. C., Lin, L., Giacomini, K., Naranjo, A., Van Ryn, C., Parisi, M. T., Shulkin, B. L., Yanik, G. A., Kreissman, S. G., Hogarty, M., Matthay, K. K., & DuBois, S. G. (2016). Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group. European journal of nuclear medicine and molecular imaging, 43(7), 1396. https://doi.org/10.1007/s00259-016-3381-x
Temple, William, et al. "Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group." European journal of nuclear medicine and molecular imaging vol. 43,7 (2016): 1396. doi: https://doi.org/10.1007/s00259-016-3381-x
Temple W, Mendelsohn L, Kim GE, Nekritz E, Gustafson WC, Lin L, Giacomini K, Naranjo A, Van Ryn C, Parisi MT, Shulkin BL, Yanik GA, Kreissman SG, Hogarty M, Matthay KK, DuBois SG. Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1396. doi: 10.1007/s00259-016-3381-x. PMID: 27044383.
Copy Download .nbib Format: NLM
Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers.

Clinical drug investigation

Sommers de K, Snyman JR, van Wyk M.
PMID: 18370554
Clin Drug Investig. 1998;16(4):329-33. doi: 10.2165/00044011-199816040-00007.

OBJECTIVE: The present placebo-controlled study was designed to compare the effect of acute pretreatment with dexfenfluramine and fluoxetine on the plasma aldosterone response to metoclopramide. STUDY PARTICIPANTS AND DESIGN: Ten healthy ambulatory male volunteers participated. Following a single-blind, randomised...

Cite
Sommers de K, Snyman JR, van Wyk M. Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers. Clin Drug Investig. 1998;16(4):329-33doi: 10.2165/00044011-199816040-00007.
Sommers, d. e. . K., Snyman, J. R., & van Wyk, M. (1998). Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers. Clinical drug investigation, 16(4), 329-33. https://doi.org/10.2165/00044011-199816040-00007
Sommers, de K, et al. "Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers." Clinical drug investigation vol. 16,4 (1998): 329-33. doi: https://doi.org/10.2165/00044011-199816040-00007
Sommers de K, Snyman JR, van Wyk M. Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers. Clin Drug Investig. 1998;16(4):329-33. doi: 10.2165/00044011-199816040-00007. PMID: 18370554.
Copy Download .nbib Format: NLM
Measurement of differential inhibition of COX-1 and COX-2 and the pharmacology of selective inhibitors.

Drugs of today (Barcelona, Spain : 1998)

Pairet M, van Ryn J.
PMID: 12973430
Drugs Today (Barc). 1999 Apr-May;35(4):251-65. doi: 10.1358/dot.1999.35.4-5.552201.

Since the discovery of a second isoenzyme of cyclooxygenase (COX)-2, it has been hypothesized that the antiinflammatory effects of non-steroidal antiinflammatory drugs (NSAIDs) are dependent on their inhibition of COX-2, whereas inhibition of constitutive COX-1 is responsible for their...

Cite
Pairet M, van Ryn J. Measurement of differential inhibition of COX-1 and COX-2 and the pharmacology of selective inhibitors. Drugs Today (Barc). 1999;35(4):251-65doi: 10.1358/dot.1999.35.4-5.552201.
Pairet, M., & van Ryn, J. (1999). Measurement of differential inhibition of COX-1 and COX-2 and the pharmacology of selective inhibitors. Drugs of today (Barcelona, Spain : 1998), 35(4), 251-65. https://doi.org/10.1358/dot.1999.35.4-5.552201
Pairet, M, and van Ryn, J. "Measurement of differential inhibition of COX-1 and COX-2 and the pharmacology of selective inhibitors." Drugs of today (Barcelona, Spain : 1998) vol. 35,4 (1999): 251-65. doi: https://doi.org/10.1358/dot.1999.35.4-5.552201
Pairet M, van Ryn J. Measurement of differential inhibition of COX-1 and COX-2 and the pharmacology of selective inhibitors. Drugs Today (Barc). 1999 Apr-May;35(4):251-65. doi: 10.1358/dot.1999.35.4-5.552201. PMID: 12973430.
Copy Download .nbib Format: NLM
Infants with Tyrosinemia Type 1: Should phenylalanine be supplemented?.

JIMD reports

van Vliet D, van Dam E, van Rijn M, Derks TG, Venema-Liefaard G, Hitzert MM, Lunsing RJ, Heiner-Fokkema MR, van Spronsen FJ.
PMID: 25256450
JIMD Rep. 2015;18:117-24. doi: 10.1007/8904_2014_358. Epub 2014 Sep 26.

Tyrosinemia type 1 (HT1) is an inborn error of tyrosine catabolism caused by fumarylacetoacetase deficiency. Biochemically, this results in accumulation of toxic metabolites including succinylacetone. Clinically, HT1 is characterized by severe liver, kidney, and neurological problems. Treatment with NTBC...

Cite
van Vliet D, van Dam E, van Rijn M, et al. Infants with Tyrosinemia Type 1: Should phenylalanine be supplemented?. JIMD Rep. 2014;18:117-24doi: 10.1007/8904_2014_358.
van Vliet, D., van Dam, E., van Rijn, M., Derks, T. G., Venema-Liefaard, G., Hitzert, M. M., Lunsing, R. J., Heiner-Fokkema, M. R., & van Spronsen, F. J. (2015). Infants with Tyrosinemia Type 1: Should phenylalanine be supplemented?. JIMD reports, 18117-24. https://doi.org/10.1007/8904_2014_358
van Vliet, Danique, et al. "Infants with Tyrosinemia Type 1: Should phenylalanine be supplemented?." JIMD reports vol. 18 (2015): 117-24. doi: https://doi.org/10.1007/8904_2014_358
van Vliet D, van Dam E, van Rijn M, Derks TG, Venema-Liefaard G, Hitzert MM, Lunsing RJ, Heiner-Fokkema MR, van Spronsen FJ. Infants with Tyrosinemia Type 1: Should phenylalanine be supplemented?. JIMD Rep. 2015;18:117-24. doi: 10.1007/8904_2014_358. Epub 2014 Sep 26. PMID: 25256450; PMCID: PMC4361924.
Copy Download .nbib Format: NLM
Informal Training Experiences and Explicit Bias Against African Americans among Medical Students.

Social psychology quarterly

Burke SE, Dovidio JF, Perry SP, Burgess DJ, Hardeman RR, Phelan SM, Cunningham BA, Yeazel MW, Przedworski JM, van Ryn M.
PMID: 31452559
Soc Psychol Q. 2017 Mar;80(1):65-84. doi: 10.1177/0190272516668166. Epub 2017 Mar 01.

Despite the widespread inclusion of diversity-related curricula in US medical training, racial disparities in the quality of care and physician bias in medical treatment persist. The present study examined the effects of both formal and informal experiences on non-African...

Cite
Burke SE, Dovidio JF, Perry SP, et al. Informal Training Experiences and Explicit Bias Against African Americans among Medical Students. Soc Psychol Q. 2017;80(1):65-84doi: 10.1177/0190272516668166.
Burke, S. E., Dovidio, J. F., Perry, S. P., Burgess, D. J., Hardeman, R. R., Phelan, S. M., Cunningham, B. A., Yeazel, M. W., Przedworski, J. M., & van Ryn, M. (2017). Informal Training Experiences and Explicit Bias Against African Americans among Medical Students. Social psychology quarterly, 80(1), 65-84. https://doi.org/10.1177/0190272516668166
Burke, Sara E, et al. "Informal Training Experiences and Explicit Bias Against African Americans among Medical Students." Social psychology quarterly vol. 80,1 (2017): 65-84. doi: https://doi.org/10.1177/0190272516668166
Burke SE, Dovidio JF, Perry SP, Burgess DJ, Hardeman RR, Phelan SM, Cunningham BA, Yeazel MW, Przedworski JM, van Ryn M. Informal Training Experiences and Explicit Bias Against African Americans among Medical Students. Soc Psychol Q. 2017 Mar;80(1):65-84. doi: 10.1177/0190272516668166. Epub 2017 Mar 01. PMID: 31452559; PMCID: PMC6709698.
Copy Download .nbib Format: NLM
Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy.

Molecular therapy. Methods & clinical development

Wuebbles RD, Cruz V, Van Ry P, Barraza-Flores P, Brewer PD, Jones P, Burkin DJ.
PMID: 30788383
Mol Ther Methods Clin Dev. 2019 Jan 22;13:145-153. doi: 10.1016/j.omtm.2019.01.004. eCollection 2019 Jun 14.

Duchenne muscular dystrophy (DMD) is a devastating disease caused by mutations in the dystrophin gene that result in the complete absence of dystrophin protein. We have shown previously that recombinant mouse Galectin-1 treatment improves physiological and histological outcome measures...

Cite
Wuebbles RD, Cruz V, Van Ry P, et al. Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy. Mol Ther Methods Clin Dev. 2019;13:145-153doi: 10.1016/j.omtm.2019.01.004.
Wuebbles, R. D., Cruz, V., Van Ry, P., Barraza-Flores, P., Brewer, P. D., Jones, P., & Burkin, D. J. (2019). Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy. Molecular therapy. Methods & clinical development, 13145-153. https://doi.org/10.1016/j.omtm.2019.01.004
Wuebbles, Ryan D, et al. "Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy." Molecular therapy. Methods & clinical development vol. 13 (2019): 145-153. doi: https://doi.org/10.1016/j.omtm.2019.01.004
Wuebbles RD, Cruz V, Van Ry P, Barraza-Flores P, Brewer PD, Jones P, Burkin DJ. Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy. Mol Ther Methods Clin Dev. 2019 Jan 22;13:145-153. doi: 10.1016/j.omtm.2019.01.004. eCollection 2019 Jun 14. PMID: 30788383; PMCID: PMC6369265.
Copy Download .nbib Format: NLM
Readmission and mortality in patients ≥70 years with acute myocardial infarction or heart failure in the Netherlands: a retrospective cohort study of incidences and changes in risk factors over time.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Jepma P, Ter Riet G, van Rijn M, Latour CHM, Peters RJG, Scholte Op Reimer WJM, Buurman BM.
PMID: 30715672
Neth Heart J. 2019 Mar;27(3):134-141. doi: 10.1007/s12471-019-1227-4.

OBJECTIVES: To determine the risk of first unplanned all-cause readmission and mortality of patients ≥70 years with acute myocardial infarction (AMI) or heart failure (HF) and to explore which effects of baseline risk factors vary over time.METHODS: A retrospective...

Cite
Jepma P, Ter Riet G, van Rijn M, et al. Readmission and mortality in patients ≥70 years with acute myocardial infarction or heart failure in the Netherlands: a retrospective cohort study of incidences and changes in risk factors over time. Neth Heart J. 2019;27(3):134-141doi: 10.1007/s12471-019-1227-4.
Jepma, P., Ter Riet, G., van Rijn, M., Latour, C. H. M., Peters, R. J. G., Scholte Op Reimer, W. J. M., & Buurman, B. M. (2019). Readmission and mortality in patients ≥70 years with acute myocardial infarction or heart failure in the Netherlands: a retrospective cohort study of incidences and changes in risk factors over time. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 27(3), 134-141. https://doi.org/10.1007/s12471-019-1227-4
Jepma, P, et al. "Readmission and mortality in patients ≥70 years with acute myocardial infarction or heart failure in the Netherlands: a retrospective cohort study of incidences and changes in risk factors over time." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 27,3 (2019): 134-141. doi: https://doi.org/10.1007/s12471-019-1227-4
Jepma P, Ter Riet G, van Rijn M, Latour CHM, Peters RJG, Scholte Op Reimer WJM, Buurman BM. Readmission and mortality in patients ≥70 years with acute myocardial infarction or heart failure in the Netherlands: a retrospective cohort study of incidences and changes in risk factors over time. Neth Heart J. 2019 Mar;27(3):134-141. doi: 10.1007/s12471-019-1227-4. PMID: 30715672; PMCID: PMC6393584.
Copy Download .nbib Format: NLM
The public uptake of information about antibiotic resistance in the Netherlands.

Public understanding of science (Bristol, England)

van Rijn M, Haverkate M, Achterberg P, Timen A.
PMID: 30755136
Public Underst Sci. 2019 May;28(4):486-503. doi: 10.1177/0963662518823701. Epub 2019 Feb 12.

In this study, we test to what extent an educational video on the intricacies of antibiotic resistance affects public attitudes towards antibiotic resistance and how such information is absorbed by the most likely targets of public health campaigns. We...

Cite
van Rijn M, Haverkate M, Achterberg P, et al. The public uptake of information about antibiotic resistance in the Netherlands. Public Underst Sci. 2019;28(4):486-503doi: 10.1177/0963662518823701.
van Rijn, M., Haverkate, M., Achterberg, P., & Timen, A. (2019). The public uptake of information about antibiotic resistance in the Netherlands. Public understanding of science (Bristol, England), 28(4), 486-503. https://doi.org/10.1177/0963662518823701
van Rijn, Michiel, et al. "The public uptake of information about antibiotic resistance in the Netherlands." Public understanding of science (Bristol, England) vol. 28,4 (2019): 486-503. doi: https://doi.org/10.1177/0963662518823701
van Rijn M, Haverkate M, Achterberg P, Timen A. The public uptake of information about antibiotic resistance in the Netherlands. Public Underst Sci. 2019 May;28(4):486-503. doi: 10.1177/0963662518823701. Epub 2019 Feb 12. PMID: 30755136; PMCID: PMC7323777.
Copy Download .nbib Format: NLM
Increased Awakenings From Non-rapid Eye Movement Sleep Explain Differences in Dream Recall Frequency in Healthy Individuals.

Frontiers in human neuroscience

van Wyk M, Solms M, Lipinska G.
PMID: 31680920
Front Hum Neurosci. 2019 Oct 15;13:370. doi: 10.3389/fnhum.2019.00370. eCollection 2019.

BACKGROUND: Dreaming is a universal experience, yet there is considerable inter-individual variability in dream recall frequency (DRF). One dominant model, the "arousal-retrieval" model, posits that intra-sleep wakefulness is required for dream traces to be encoded into long-term storage, essentially...

Cite
van Wyk M, Solms M, Lipinska G. Increased Awakenings From Non-rapid Eye Movement Sleep Explain Differences in Dream Recall Frequency in Healthy Individuals. Front Hum Neurosci. 2019;13:370doi: 10.3389/fnhum.2019.00370.
van Wyk, M., Solms, M., & Lipinska, G. (2019). Increased Awakenings From Non-rapid Eye Movement Sleep Explain Differences in Dream Recall Frequency in Healthy Individuals. Frontiers in human neuroscience, 13370. https://doi.org/10.3389/fnhum.2019.00370
van Wyk, Mariza, et al. "Increased Awakenings From Non-rapid Eye Movement Sleep Explain Differences in Dream Recall Frequency in Healthy Individuals." Frontiers in human neuroscience vol. 13 (2019): 370. doi: https://doi.org/10.3389/fnhum.2019.00370
van Wyk M, Solms M, Lipinska G. Increased Awakenings From Non-rapid Eye Movement Sleep Explain Differences in Dream Recall Frequency in Healthy Individuals. Front Hum Neurosci. 2019 Oct 15;13:370. doi: 10.3389/fnhum.2019.00370. eCollection 2019. PMID: 31680920; PMCID: PMC6803546.
Copy Download .nbib Format: NLM
Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates.

Science (New York, N.Y.)

Corbett KS, Gagne M, Wagner DA, O' Connell S, Narpala SR, Flebbe DR, Andrew SF, Davis RL, Flynn B, Johnston TS, Stringham CD, Lai L, Valentin D, Van Ry A, Flinchbaugh Z, Werner AP, Moliva JI, Sriparna M, O'Dell S, Schmidt SD, Tucker C, Choi A, Koch M, Bock KW, Minai M, Nagata BM, Alvarado GS, Henry AR, Laboune F, Schramm CA, Zhang Y, Yang ES, Wang L, Choe M, Boyoglu-Barnum S, Wei S, Lamb E, Nurmukhambetova ST, Provost SJ, Donaldson MM, Marquez J, Todd JM, Cook A, Dodson A, Pekosz A, Boritz E, Ploquin A, Doria-Rose N, Pessaint L, Andersen H, Foulds KE, Misasi J, Wu K, Carfi A, Nason MC, Mascola J, Moore IN, Edwards DK, Lewis MG, Suthar MS, Roederer M, McDermott A, Douek DC, Sullivan NJ, Graham BS, Seder RA.
PMID: 34672695
Science. 2021 Dec 10;374(6573):1343-1353. doi: 10.1126/science.abl8912. Epub 2021 Oct 21.

[Figure: see text].

Cite
Corbett KS, Gagne M, Wagner DA, et al. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates. Science. 2021;374(6573):1343-1353doi: 10.1126/science.abl8912.
Corbett, K. S., Gagne, M., Wagner, D. A., O' Connell, S., Narpala, S. R., Flebbe, D. R., Andrew, S. F., Davis, R. L., Flynn, B., Johnston, T. S., Stringham, C. D., Lai, L., Valentin, D., Van Ry, A., Flinchbaugh, Z., Werner, A. P., Moliva, J. I., Sriparna, M., O'Dell, S., Schmidt, S. D., Tucker, C., Choi, A., Koch, M., Bock, K. W., Minai, M., Nagata, B. M., Alvarado, G. S., Henry, A. R., Laboune, F., Schramm, C. A., Zhang, Y., Yang, E. S., Wang, L., Choe, M., Boyoglu-Barnum, S., Wei, S., Lamb, E., Nurmukhambetova, S. T., Provost, S. J., Donaldson, M. M., Marquez, J., Todd, J. M., Cook, A., Dodson, A., Pekosz, A., Boritz, E., Ploquin, A., Doria-Rose, N., Pessaint, L., Andersen, H., Foulds, K. E., Misasi, J., Wu, K., Carfi, A., Nason, M. C., Mascola, J., Moore, I. N., Edwards, D. K., Lewis, M. G., Suthar, M. S., Roederer, M., McDermott, A., Douek, D. C., Sullivan, N. J., Graham, B. S., & Seder, R. A. (2021). Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates. Science (New York, N.Y.), 374(6573), 1343-1353. https://doi.org/10.1126/science.abl8912
Corbett, Kizzmekia S, et al. "Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates." Science (New York, N.Y.) vol. 374,6573 (2021): 1343-1353. doi: https://doi.org/10.1126/science.abl8912
Corbett KS, Gagne M, Wagner DA, O' Connell S, Narpala SR, Flebbe DR, Andrew SF, Davis RL, Flynn B, Johnston TS, Stringham CD, Lai L, Valentin D, Van Ry A, Flinchbaugh Z, Werner AP, Moliva JI, Sriparna M, O'Dell S, Schmidt SD, Tucker C, Choi A, Koch M, Bock KW, Minai M, Nagata BM, Alvarado GS, Henry AR, Laboune F, Schramm CA, Zhang Y, Yang ES, Wang L, Choe M, Boyoglu-Barnum S, Wei S, Lamb E, Nurmukhambetova ST, Provost SJ, Donaldson MM, Marquez J, Todd JM, Cook A, Dodson A, Pekosz A, Boritz E, Ploquin A, Doria-Rose N, Pessaint L, Andersen H, Foulds KE, Misasi J, Wu K, Carfi A, Nason MC, Mascola J, Moore IN, Edwards DK, Lewis MG, Suthar MS, Roederer M, McDermott A, Douek DC, Sullivan NJ, Graham BS, Seder RA. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates. Science. 2021 Dec 10;374(6573):1343-1353. doi: 10.1126/science.abl8912. Epub 2021 Oct 21. PMID: 34672695.
Copy Download .nbib Format: NLM
Erratum: Aluwé, M. et al. Exploratory Survey on European Consumer and Stakeholder Attitudes towards Alternatives for Surgical Castration of Piglets. .

Animals : an open access journal from MDPI

Aluwé M, Heyrman E, Almeida JM, Babol J, Battacone G, Čítek J, Font I Furnols M, Getya A, Karolyi D, Kostyra E, Kress K, Kušec G, Mörlein D, Semenova A, Škrlep M, Stoyanchev T, Tomašević I, Tudoreanu L, Van Son M, Żakowska-Biemans S, Zamaratskaia G, Van den Broeke A, Egea M.
PMID: 33327668
Animals (Basel). 2020 Dec 14;10(12). doi: 10.3390/ani10122388.

The authors wish to make the following corrections to this paper [...].

Cite
Aluwé M, Heyrman E, Almeida JM, et al. Erratum: Aluwé, M. et al. Exploratory Survey on European Consumer and Stakeholder Attitudes towards Alternatives for Surgical Castration of Piglets. . Animals (Basel). 2020;10(12)doi: 10.3390/ani10122388.
Aluwé, M., Heyrman, E., Almeida, J. M., Babol, J., Battacone, G., Čítek, J., Font I Furnols, M., Getya, A., Karolyi, D., Kostyra, E., Kress, K., Kušec, G., Mörlein, D., Semenova, A., Škrlep, M., Stoyanchev, T., Tomašević, I., Tudoreanu, L., Van Son, M., Żakowska-Biemans, S., Zamaratskaia, G., Van den Broeke, A., & Egea, M. (2020). Erratum: Aluwé, M. et al. Exploratory Survey on European Consumer and Stakeholder Attitudes towards Alternatives for Surgical Castration of Piglets. . Animals : an open access journal from MDPI, 10(12), . https://doi.org/10.3390/ani10122388
Aluwé, Marijke, et al. "Erratum: Aluwé, M. et al. Exploratory Survey on European Consumer and Stakeholder Attitudes towards Alternatives for Surgical Castration of Piglets. ." Animals : an open access journal from MDPI vol. 10,12 (2020). doi: https://doi.org/10.3390/ani10122388
Aluwé M, Heyrman E, Almeida JM, Babol J, Battacone G, Čítek J, Font I Furnols M, Getya A, Karolyi D, Kostyra E, Kress K, Kušec G, Mörlein D, Semenova A, Škrlep M, Stoyanchev T, Tomašević I, Tudoreanu L, Van Son M, Żakowska-Biemans S, Zamaratskaia G, Van den Broeke A, Egea M. Erratum: Aluwé, M. et al. Exploratory Survey on European Consumer and Stakeholder Attitudes towards Alternatives for Surgical Castration of Piglets. . Animals (Basel). 2020 Dec 14;10(12). doi: 10.3390/ani10122388. PMID: 33327668; PMCID: PMC7764957.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 113 entries